RLAY
Relay Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.90B
P/E Ratio
—
EPS
$-1.56
Beta
1.75
52W High
$17.32
52W Low
$2.83
50-Day MA
$12.79
200-Day MA
$8.32
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Relay Therapeutics Inc
Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $10.68M |
| Gross Profit (TTM) | $-245.58M |
| EBITDA | $-293.61M |
| Operating Margin | -2620.00% |
| Return on Equity | -40.00% |
| Return on Assets | -24.70% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $3.26 |
| Price-to-Book | 4.52 |
| Price-to-Sales (TTM) | 271.85 |
| EV/Revenue | 214.86 |
| EV/EBITDA | -0.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -60.90% |
| Shares Outstanding | $214.50M |
| Float | $136.00M |
| % Insiders | 1.39% |
| % Institutions | 86.87% |
Historical Volatility
HV 10-Day
57.35%
HV 20-Day
68.54%
HV 30-Day
67.40%
HV 60-Day
74.52%
HV Rank
46.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($23.67 target)
2
Strong Buy10
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026